These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 33262240)

  • 1. Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways.
    Khanolkar RA; Clark ST; Wang PW; Hwang DM; Yau YCW; Waters VJ; Guttman DS
    mSystems; 2020 Dec; 5(6):. PubMed ID: 33262240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of
    Reece E; Bettio PHA; Renwick J
    Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356747
    [No Abstract]   [Full Text] [Related]  

  • 3. The airway microbiome in cystic fibrosis and implications for treatment.
    Zemanick ET; Sagel SD; Harris JK
    Curr Opin Pediatr; 2011 Jun; 23(3):319-24. PubMed ID: 21494150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Modeling of Cystic Fibrosis Airway Communities Predicts Mechanisms of Pathogen Dominance.
    Henson MA; Orazi G; Phalak P; O'Toole GA
    mSystems; 2019; 4(2):. PubMed ID: 31020043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dpr-mediated H
    Rogers RR; Kesthely CA; Jean-Pierre F; El Hafi B; O'Toole GA
    J Bacteriol; 2024 Jun; ():e0017624. PubMed ID: 38940597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture.
    Sibley CD; Surette MG
    Can J Microbiol; 2011 Feb; 57(2):69-77. PubMed ID: 21326348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future.
    Thornton CS; Parkins MD
    Semin Respir Crit Care Med; 2023 Apr; 44(2):269-286. PubMed ID: 36623820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome through Antibiotic Therapy.
    Raghuvanshi R; Vasco K; Vázquez-Baeza Y; Jiang L; Morton JT; Li D; Gonzalez A; DeRight Goldasich L; Humphrey G; Ackermann G; Swafford AD; Conrad D; Knight R; Dorrestein PC; Quinn RA
    mSystems; 2020 Jun; 5(3):. PubMed ID: 32576651
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
    Widder S; Carmody L; Opron K; Kalikin L; Caverly L; LiPuma J
    Res Sq; 2024 Mar; ():. PubMed ID: 38562856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
    Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
    BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.
    Magalhães AP; Azevedo NF; Pereira MO; Lopes SP
    Appl Microbiol Biotechnol; 2016 Feb; 100(3):1163-1181. PubMed ID: 26637419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
    O'Brien S; Fothergill JL
    FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial ecology and adaptation in cystic fibrosis airways.
    Yang L; Jelsbak L; Molin S
    Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
    Widder S; Opron K; Carmody LA; Kalikin LM; Caverly LJ; LiPuma JJ
    bioRxiv; 2023 Jul; ():. PubMed ID: 37546739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa Can Inhibit Growth of Streptococcal Species via Siderophore Production.
    Scott JE; Li K; Filkins LM; Zhu B; Kuchma SL; Schwartzman JD; O'Toole GA
    J Bacteriol; 2019 Apr; 201(8):. PubMed ID: 30718303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Contributions of Anaerobes in Cystic Fibrosis Airways.
    Thornton CS; Surette MG
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33115848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.